Treatment for Primary HSV Outbreak
For a primary HSV outbreak, initiate oral valacyclovir 1 gram twice daily for 7-10 days, starting as soon as possible after symptom onset, with treatment extended if healing is incomplete after 10 days. 1
First-Line Treatment Options
The CDC recommends the following equivalent regimens for first clinical episodes of genital herpes 1:
- Valacyclovir 1 gram orally twice daily for 7-10 days (preferred due to convenient dosing) 1, 2
- Acyclovir 400 mg orally three times daily for 7-10 days 1, 2
- Acyclovir 200 mg orally five times daily for 7-10 days 1
- Famciclovir 250 mg orally three times daily for 7-10 days 1
Treatment duration is longer for primary episodes (7-10 days) compared to recurrent episodes (5 days) because primary infections are more severe and require more time for viral suppression. 1
Critical Timing Considerations
- Initiate treatment within 72 hours of symptom onset for maximum effectiveness 1
- Treatment started during the prodromal period (before visible lesions) is most effective 1, 2
- Extend treatment beyond 10 days if lesions have not completely healed 1, 2
What NOT to Use
Topical acyclovir is substantially less effective than oral systemic therapy and should not be used. 1, 3, 2 The Infectious Diseases Society of America explicitly states that topical formulations do not provide adequate viral suppression for primary outbreaks 1.
Special Populations
Immunocompromised Patients
- Immunosuppressed patients (including those with IBD on immunosuppressive therapy or HIV-infected individuals) should receive appropriate antiviral treatment and may require longer courses than standard 7-10 day regimens 4, 1
- For severe HSV infections in immunocompromised hosts, consider intravenous acyclovir, particularly for encephalitis, disseminated disease, or severe mucocutaneous involvement 4
- HIV-infected patients require close monitoring and extended therapy duration 1
Pregnant Women
- Primary HSV infection during pregnancy carries significant fetal risk (30-50% neonatal transmission if acquired in third trimester) 5
- Oral antivirals (valacyclovir, acyclovir, famciclovir) can be used during pregnancy, though safety data are limited 5
- Primary outbreaks in first trimester have been associated with neonatal chorioretinitis, microcephaly, and skin lesions 5
Treatment Failure and Resistance
If lesions do not begin to resolve within 7-10 days of appropriately dosed antiviral therapy, suspect acyclovir resistance. 4, 1, 3
For confirmed or suspected acyclovir-resistant HSV 4, 1, 3, 6:
- Obtain viral culture and susceptibility testing 1
- Switch to IV foscarnet 40 mg/kg every 8 hours 4, 1, 3
- Acyclovir resistance is more common in immunocompromised patients with repeated antiviral exposure 4, 6
Patient Counseling Essentials
Patients must understand 1, 2:
- HSV is a chronic, incurable viral infection with potential for recurrence 1, 2
- Antiviral medications control symptoms but do not eradicate latent virus 1, 3
- Asymptomatic viral shedding can occur, allowing transmission even without visible lesions 1, 3
- Abstain from sexual activity when lesions or prodromal symptoms are present 1
- Consistent condom use reduces but does not eliminate transmission risk (approximately 50% reduction) 1
Post-Treatment Management
- Provide a prescription for episodic therapy to self-initiate at first sign of recurrence 2
- Consider daily suppressive therapy if patient develops ≥6 recurrences per year 1, 3, 2
- Suppressive therapy options include valacyclovir 500 mg to 1 gram daily, acyclovir 400 mg twice daily, or famciclovir 250 mg twice daily 1, 3
Common Pitfalls to Avoid
- Do not delay treatment waiting for laboratory confirmation—start empirically based on clinical presentation 1
- Do not use shorter 3-5 day courses appropriate for recurrent episodes; primary outbreaks require 7-10 days minimum 1
- Do not prescribe topical acyclovir as monotherapy 1, 3, 2
- Do not assume treatment failure means resistance without giving adequate time (7-10 days) for response 1, 6